Efficient treatments reduce the cost-efficiency of breast cancer screening

Research output: Contribution to journalEditorialpeer-review

3 Citations (Scopus)


In this issue, Birnbaum and colleagues evaluate whether the availability of efficient adjuvant and chemotherapy treatments would have changed reductions in the risk for breast cancer death reported by randomized trials on breast cancer screening. The editorialist discusses these results and the implications for women having breast cancer screening.
Original languageEnglish
Pages (from-to)297-298
Number of pages2
JournalAnnals of Internal Medicine
Issue number4
Publication statusPublished - 16 Feb 2016


  • breast screening
  • breast neoplasm screening
  • breast cancer

Cite this